Overview

The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography

Status:
Unknown status

Trial end date:
2021-09-30

Target enrollment:

Participant gender:

Summary

the purpose of this study is to show that alirocumab with statin therapy have a s tronger stabilizing effect on vulnerable plaque in coronary artery disease than statin alone administration

Phase:

Phase 4

Details

Lead Sponsor:

Kobe University

Treatments:

Antibodies, Monoclonal
Rosuvastatin Calcium